Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients
Completed
- Conditions
- Premenstrual Syndrome
- Registration Number
- NCT00229346
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
Assessing FM and psychiatric disorder in patients suffering from PMS or PMDD
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- PMDD
- PMS
- Referral to gynecologist clinic without symptoms of PMS or PMDD
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link premenstrual syndrome to fibromyalgia and psychiatric symptoms in NCT00229346?
Are there specific biomarkers that correlate with fibromyalgia severity in PMS and PMDD populations?
How do psychiatric comorbidities in PMS/PMDD patients influence fibromyalgia diagnosis and treatment outcomes?
What are the potential adverse events associated with psychiatric interventions for PMS/PMDD-related fibromyalgia?
What combination therapies show promise for managing both PMS/PMDD and fibromyalgia in observational studies?
Trial Locations
- Locations (1)
Chaim Sheba Medical Center
🇮🇱Ramat-Gan, Israel
Chaim Sheba Medical Center🇮🇱Ramat-Gan, Israel